U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 29

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr10:124269618
GRCh38:
Chr10:122510102
HTRA1A376VCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Uncertain significance
(Nov 24, 2023)
no assertion criteria provided
2.
GRCh37:
Chr10:124221343-124221346
GRCh38:
Chr10:122461827-122461830
ARMS2, HTRA1R59fsCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Pathogenic
(Dec 2, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr10:124249035
GRCh38:
Chr10:122489519
HTRA1N224fsCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Likely pathogenic
(Sep 10, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr10:124266286
GRCh38:
Chr10:122506770
HTRA1F286SCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Uncertain significance
(May 23, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr10:124266402
GRCh38:
Chr10:122506886
HTRA1Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Likely pathogenic
(May 22, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr10:124221451
GRCh38:
Chr10:122461935
HTRA1V95LCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Uncertain significance
(Jun 15, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr10:124266249
GRCh38:
Chr10:122506733
HTRA1R274WInborn genetic diseases, not provided, Age related macular degeneration 7,
CARASIL syndrome, Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
Uncertain significance
(Nov 10, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr10:124248955
GRCh38:
Chr10:122489439
HTRA1R197QCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Uncertain significance
(Jan 3, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr10:124266334
GRCh38:
Chr10:122506818
HTRA1R302QCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, CARASIL syndrome, not provided
Pathogenic/Likely pathogenic
(Aug 13, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr10:124248441
GRCh38:
Chr10:122488925
HTRA1R166Cnot provided, Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Pathogenic/Likely pathogenic
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr10:124266896
GRCh38:
Chr10:122507380
HTRA1S328LCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Uncertain significance
(Aug 23, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr10:124273671
GRCh38:
Chr10:122514155
HTRA1CARASIL syndrome, Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided
Benign
(Aug 10, 2021)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr10:124266249
GRCh38:
Chr10:122506733
HTRA1R274GCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Likely pathogenic
(Jul 22, 2021)
no assertion criteria provided
14.
GRCh37:
Chr10:124266264
GRCh38:
Chr10:122506748
HTRA1V279MCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not providedUncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr10:124221306
GRCh38:
Chr10:122461790
HTRA1C46*Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Uncertain significance
(Oct 22, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr10:124266400
GRCh38:
Chr10:122506884
HTRA1N324TCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Likely pathogenic
(Apr 13, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr10:124266294
GRCh38:
Chr10:122506778
HTRA1Q289*Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not providedPathogenic
(Nov 3, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr10:124266256
GRCh38:
Chr10:122506740
HTRA1G276ACerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Likely pathogenic
(Apr 13, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr10:124249132
GRCh38:
Chr10:122489616
HTRA1I256TCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Pathogenic
(Apr 13, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr10:124248488
GRCh38:
Chr10:122488972
HTRA1A182fsCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not providedPathogenic
(Dec 8, 2021)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr10:124248481
GRCh38:
Chr10:122488965
HTRA1I179NCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Likely pathogenic
(Apr 13, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr10:124221527
GRCh38:
Chr10:122462011
HTRA1G120DCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Likely pathogenic
(Apr 13, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr10:124271595
GRCh38:
Chr10:122512079
HTRA1Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided, Macular degeneration,
CARASIL syndrome
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr10:124271589
GRCh38:
Chr10:122512073
HTRA1Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided, Macular degeneration,
CARASIL syndrome
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr10:124266885
GRCh38:
Chr10:122507369
HTRA1Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Pathogenic
(Sep 21, 2016)
no assertion criteria provided
26.
GRCh37:
Chr10:124266281
GRCh38:
Chr10:122506765
HTRA1S284RCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Pathogenic
(Sep 21, 2016)
no assertion criteria provided
27.
GRCh37:
Chr10:124248462
GRCh38:
Chr10:122488946
HTRA1A173PCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Pathogenic
(Sep 21, 2016)
no assertion criteria provided
28.
GRCh37:
Chr10:124248442
GRCh38:
Chr10:122488926
HTRA1R166LCerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Pathogenic
(Sep 1, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr10:124266333
GRCh38:
Chr10:122506817
HTRA1R302*Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not providedPathogenic/Likely pathogenic
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination